Publication | Closed Access

Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: An in vitro and in vivo evaluation

NanoparticlesNanomedicineHigh DrugEngineeringPolymer-drug ConjugateMedicinePharmaceutical NanotechnologyMultidrug ResistanceBreast CancerNano-drug DeliveryTumor TargetingBiomedical EngineeringPharmacology